BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 14562396)

  • 1. Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome.
    Portincasa P; Moschetta A; Baldassarre G; Altomare DF; Palasciano G
    World J Gastroenterol; 2003 Oct; 9(10):2293-9. PubMed ID: 14562396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasonographic assessment of liquid gastric emptying and antral motility according to the subtypes of irritable bowel syndrome in children.
    Devanarayana NM; Rajindrajith S; Bandara C; Shashiprabha G; Benninga MA
    J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):443-8. PubMed ID: 23201712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric dysmotility and gastrointestinal symptoms in myalgic encephalomyelitis/chronic fatigue syndrome.
    Steinsvik EK; Hausken T; Fluge Ø; Mella O; Gilja OH
    Scand J Gastroenterol; 2023 Jul; 58(7):718-725. PubMed ID: 36728717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in gastrointestinal symptoms according to gender in Rome II positive IBS and dyspepsia in a Latin American population.
    Schmulson M; Adeyemo M; Gutiérrez-Reyes G; Charúa-Guindic L; Farfán-Labonne B; Ostrosky-Solis F; Díaz-Anzaldúa A; Medina L; Chang L
    Am J Gastroenterol; 2010 Apr; 105(4):925-32. PubMed ID: 20179693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutrient drink test: A promising new tool for irritable bowel syndrome diagnosis.
    Estremera-Arevalo F; Barcelo M; Serrano B; Rey E
    World J Gastroenterol; 2019 Feb; 25(7):837-847. PubMed ID: 30809083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters.
    Haag S; Talley NJ; Holtmann G
    Gut; 2004 Oct; 53(10):1445-51. PubMed ID: 15361493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of coexisting irritable bowel syndrome and non-erosive reflux disease on postprandial abdominal fullness and sleep disorders in functional dyspepsia.
    Futagami S; Yamawaki H; Shimpuku M; Izumi N; Wakabayashi T; Kodaka Y; Nagoya H; Shindo T; Kawagoe T; Sakamoto C
    J Nippon Med Sch; 2013; 80(5):362-70. PubMed ID: 24189354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
    Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
    World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia.
    Corsetti M; Caenepeel P; Fischler B; Janssens J; Tack J
    Am J Gastroenterol; 2004 Jun; 99(6):1152-9. PubMed ID: 15180740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of upper digestive symptoms in patients with irritable bowel syndrome.
    Balboa A; Mearin F; Badía X; Benavent J; Caballero AM; Domínguez-Muñoz JE; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M;
    Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1271-7. PubMed ID: 17099375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
    Fang XC; Fan WJ; Drossman DD; Han SM; Ke MY
    World J Gastroenterol; 2022 Sep; 28(33):4861-4874. PubMed ID: 36156921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression and Somatization Are Associated With Increased Postprandial Symptoms in Patients With Irritable Bowel Syndrome.
    Van Oudenhove L; Törnblom H; Störsrud S; Tack J; Simrén M
    Gastroenterology; 2016 Apr; 150(4):866-74. PubMed ID: 26602216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors.
    Aziz I; Törnblom H; Palsson OS; Whitehead WE; Simrén M
    Am J Gastroenterol; 2018 Jul; 113(7):1017-1025. PubMed ID: 29880963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of oro-cecal transit time in patients with irritable bowel syndrome with cereal products intolerance].
    Błońska A; Konrad P; Chojnacki J; Chojnacki C
    Pol Merkur Lekarski; 2017 Mar; 42(249):116-120. PubMed ID: 28333903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alexithymia and gastrointestinal-specific anxiety in moderate to severe irritable bowel syndrome.
    Porcelli P; De Carne M; Leandro G
    Compr Psychiatry; 2014 Oct; 55(7):1647-53. PubMed ID: 25011689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS).
    Kanuri N; Cassell B; Bruce SE; White KS; Gott BM; Gyawali CP; Sayuk GS
    Neurogastroenterol Motil; 2016 Oct; 28(10):1508-17. PubMed ID: 27151081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiological Abnormalities in Functional Dyspepsia Subgroups According to the Rome III Criteria.
    Vanheel H; Carbone F; Valvekens L; Simren M; Tornblom H; Vanuytsel T; Van Oudenhove L; Tack J
    Am J Gastroenterol; 2017 Jan; 112(1):132-140. PubMed ID: 27958284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS).
    Bengtsson M; Hammar O; Mandl T; Ohlsson B
    BMC Gastroenterol; 2011 Nov; 11():122. PubMed ID: 22073983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Painful or Mild-Pain Constipation? A Clinically Useful Alternative to Classification as Irritable Bowel Syndrome with Constipation Versus Functional Constipation.
    Bouchoucha M; Devroede G; Mary F; Bon C; Bejou B; Benamouzig R
    Dig Dis Sci; 2018 Jul; 63(7):1763-1773. PubMed ID: 29492744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS.
    Jerndal P; Ringström G; Agerforz P; Karpefors M; Akkermans LM; Bayati A; Simrén M
    Neurogastroenterol Motil; 2010 Jun; 22(6):646-e179. PubMed ID: 20367800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.